Position in KROS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$334,161
-$258,179 QoQ
Shares Held
31,230
-41.8% QoQ
Ownership
0.158%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 131 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KROS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. KROS ranks #263 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in KROS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $334,161 | 31,230 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $592,340 | 53,654 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $2,038,319 | 100,114 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,577,327 | 226,127 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $3,944,617 | 295,477 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,585,683 | 155,612 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,556,020 | 161,467 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $9,934,091 | 171,071 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,180,024 | 178,994 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $11,417,976 | 172,477 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $7,691,531 | 193,449 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,742,240 | 54,650 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,258,637 | 56,213 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,231,064 | 75,669 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,166,486 | 65,941 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,997,997 | 53,110 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,071,186 | 38,769 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,864,634 | 34,289 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,835,048 | 31,363 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,192,615 | 30,147 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $339,461 | 7,993 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $891,674 | 14,487 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $148,063 | 2,099 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $37,721 | 978 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $351,205 | 9,363 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||